GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com
Index / Exbio / CD22 / Product Detail : 1A-265-T100 CD22
Related keywords:
Apr
20th
#1A-265-T100 CD22
Price : | 346 | EUR |
393 | USD | |
268 | GBP | |
1456 | Zloty | |
46377 | JPY | |
2673 | NOK | |
2864 | SEK | |
392 | CHF |
Product name : CD22
Catalog number : 1A-265-T100
Quantity: 100 tests
Availability: Yes
Supplier name : Exbio
Data sheet: Ask more or other datasheet now !
Contact us about this product :
Our team will respond you as soon as possible !
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Gentaurpub
Pathways :
WP1025: B Cell Receptor Signaling Pathway
WP1144: B Cell Receptor Signaling Pathway
WP274: B Cell Receptor Signaling Pathway
WP285: B Cell Receptor Signaling Pathway
WP794: B Cell Receptor Signaling Pathway
WP908: B Cell Receptor Signaling Pathway
Related Genes :
[Cd22 Lyb-8 Siglec2] B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)
[CD22 SIGLEC2] B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)
[CD22 SIGLEC2] B-cell receptor CD22 (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (CD antigen CD22) (Fragment)
[CD22 SIGLEC2] B-cell receptor CD22 (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (CD antigen CD22) (Fragment)
[CD22 SIGLEC2] B-cell receptor CD22 (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (CD antigen CD22) (Fragment)
[CD22 SIGLEC2] B-cell receptor CD22 (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (CD antigen CD22) (Fragment)
[] Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Fragment)
[ndhF] NAD(P)H-quinone oxidoreductase subunit 5, chloroplastic (EC 1.6.5.-) (NADH-plastoquinone oxidoreductase subunit 5) (Fragment)
[rbcL] Ribulose bisphosphate carboxylase large chain (EC 4.1.1.39) (Fragment)
[Lyn] Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)
[LYN JTK8] Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)
[Siglec10 Siglecg] Sialic acid-binding Ig-like lectin 10 (Siglec-10) (Sialic acid-binding Ig-like lectin G) (Siglec-G) (mSiglec-G)
[Lyn] Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)
[Cd24 Cd24a Ly-52] Signal transducer CD24 (Lymphocyte antigen 52) (Ly-52) (M1/69-J11D heat stable antigen) (HSA) (Nectadrin) (R13-Ag) (X62 heat stable antigen) (CD antigen CD24)
[PTPN6 HCP PTP1C] Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1)
[Ptpn6 Hcp Hcph Ptp1C] Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (70Z-SHP) (Hematopoietic cell protein-tyrosine phosphatase) (PTPTY-42) (Protein-tyrosine phosphatase 1C) (PTP-1C) (SH-PTP1) (SHP-1)
[MAG CD22 CK820_G0030195] B-cell receptor CD22 (MAG isoform 1) (MAG isoform 4) (MAG isoform 6)
[Cd79a Iga Mb-1] B-cell antigen receptor complex-associated protein alpha chain (Ig-alpha) (MB-1 membrane glycoprotein) (Membrane-bound immunoglobulin-associated protein) (Surface IgM-associated protein) (CD antigen CD79a)
[Cd79b Igb] B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b)
[CD79B B29 IGB] B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b)
[CD79A IGA MB1] B-cell antigen receptor complex-associated protein alpha chain (Ig-alpha) (MB-1 membrane glycoprotein) (Membrane-bound immunoglobulin-associated protein) (Surface IgM-associated protein) (CD antigen CD79a)
[FFAR2 FFA2 GPCR43 GPR43] Free fatty acid receptor 2 (G-protein coupled receptor 43)
[IGHV3-13] Immunoglobulin heavy variable 3-13 (Ig heavy chain V-III region BRO)
[IGHV3-48] Immunoglobulin heavy variable 3-48 (Ig heavy chain V-III region WEA)
[IGHV4-39] Immunoglobulin heavy variable 4-39 (Ig heavy chain V-II region WAH)
[IGHM] Immunoglobulin heavy constant mu (Ig mu chain C region) (Ig mu chain C region BOT) (Ig mu chain C region GAL) (Ig mu chain C region OU)
[IGKV2-30] Immunoglobulin kappa variable 2-30 (Ig kappa chain V-II region RPMI 6410)
[IGKV3-11] Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)
[IGKV3-20] Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)
[IGKV4-1] Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)
Bibliography :
[29665916] [Characteristics and Diagnostic Values of Bone Marrow Cell Morphology and Immunophenotyping in Lymphoma Cell Leukemia].
[29662041] Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies.
[29624008] Age-related changes in mRNA expression of selected surface receptors in lymphocytes of dairy calves.
[29617956] Microglia Activation in Niemann-Pick Disease, type C1 is Amendableto Therapeutic Intervention.
[29609506] Ublituximab for the treatment of CD20 positive B-cell malignancies.
[29602219] CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.
[29572500] Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.
[29572070] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4).
[29543347] Development and characterization of a camelid single-domain antibody directed to human CD22 biomarker.
[29542345] Epratuzumab for the treatment of systemic lupus erythematosus.
Enter catalog number :
Favorites Pages:
No Favorits